Featured Articles
-
Automated Trial Monitoring Workflows Make Small Teams More Efficient
4/13/2023
A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
-
Achieving Harmonious and Optimized Site Budget Negotiations
4/13/2023
Review findings from research efforts into how principal investigators survive the complex process, identify coping strategies, and combat budget negotiation challenges.
-
Detecting Variability In Adverse Event Reporting
4/13/2023
Variability in adverse event reporting can negatively impact patient safety and clinical trial data integrity. Learn how next-generation clinical monitoring can help detect and address this issue.
-
The Future Of Clinical Trial Oversight
4/13/2023
The future of clinical trial oversight will be shaped by the increasing use of decentralized trials, which require new approaches to data management. Discover how to leverage digital technology to enable a flexible approach to monitoring in today’s era of DCTs.
-
How To Double High-Performing Site Count In A Priority Indication
3/13/2023
A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.
-
The State Of Black Participation In Clinical Trials
2/24/2023
The need to design trials enrolling more demographically diverse patients is widely recognized. Learn why implementing effective, sustainable, and scalable enrollment diversity strategies remains a challenge for biopharmaceutical companies.
-
Reliable Methods For Examining Long-Term Wearables In Gait & Sway
2/21/2023
Review this evaluation framework for wear duration when confirming if wearable sensor-based methods for capturing gait and balance impairment in the free-living environment are fit for purpose.
-
A New Avenue In Breast Cancer Therapeutics
1/23/2023
Clinical trial findings may have unlocked a groundbreaking opportunity for breast cancer patients: beneficial therapy for HER2-negative patients with HER2-directed antibody-drug conjugates.
-
3 Data Linkage Use Cases To Future Proof Your Clinical Trials
12/20/2022
Discover why access to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes.
-
The Future Of Data Linkage In Clinical Trial Evidence Generation
12/20/2022
Explore key questions about the future of AI and data linkage in clinical trial evidence generation.